BioCentury
ARTICLE | Financial News

CRO Viva raises $193.9 million in Hong Kong IPO

May 8, 2019 9:34 PM UTC

Viva will begin trading Thursday after raising HK$1.5 billion (US$193.9 million) early Wednesday in an IPO that values the drug discovery services company at HK$6.6 billion (US$843.1 million).

Viva Biotech Holdings (HKSE:1873) sold 345 million shares at HK$4.41, the top of its proposed range of HK$3.42-HK$4.41 (see "CRO Viva Could Get $749M Valuation in Hong Kong Listing")...

BCIQ Company Profiles

Viva Biotech Holdings